• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

GLUCAGON-LIKE PEPTIDE 1

PPARgamma and drugs for Alzheimer’s and Diabetes

September 17, 2018Alzheimer's, Diabetes, Metabolic Disorders, Nervous System Disorders, Vizit Graphs
PPARgamma ad common drugs and two major diseases, Alzheimer’s and Diabetes

“Live graph” of PPARgamma associated with common drugs and two major diseases, Alzheimer’s and Diabetes. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

STREPTOCOCCUS PNEUMONIAE HELICOBACTER PYLORI IFNG IL23A ALZHEIMER'S DISEASE PSEUDOMONAS AERUGINOSA SOD1 DOXORUBICIN IMMUNE RESPONSE ANGIOGENESIS TP53 IL6 CELL DEATH AGING ESCHERICHIA COLI PORPHYROMONAS GINGIVALIS RHEUMATOID ARTHRITIS CANCER TNF RECEPTOR STAPHYLOCOCCUS AUREUS CELL DIFFERENTIATION BREAST CANCER CASP3 INFLAMMATION 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CD4 REMICADE CANDIDA ALBICANS DIABETES MELLITUS IL17A FOXP3 INSULIN CLOSTRIDIUM DIFFICILE CELL DIVISION CELL PROLIFERATION LISTERIA MONOCYTOGENES APOPTOTIC PROCESS METFORMIN CTLA4 ERBB-2 PARKINSON DISEASE TH17 CELLS AUTOPHAGY NEURODEGENERATIVE DISORDERS

© 2019 Biovista Vizit All Rights Reserved.